AFDO RAPS Healthcare Products Collaborative
Rumi Young



Director, Regulatory Policy

Novo Nordisk

Rumi Young, Meng, RAC, serves as the Director of Regulatory Policy at Novo Nordisk, leading a team dedicated to accelerating time to market, fostering innovation, and ensuring reasonable regulatory requirements for medical devices, diagnostics, and combination products. Previously at the FDA's CDRH Division of Drug Delivery, General Hospital, and Human Factors, Rumi played a key role as Acting Assistant Director for Injection Devices, overseeing the approval of various drug delivery injection devices and combination products. With eight years of experience at Genentech and AstraZeneca in combination product development, Rumi holds a Bachelor's in Chemistry and Chemical Biology and a Master's in Engineering in Material Science from Cornell University.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.


Stay in the know about upcoming events and breaking news from the collaborative.



Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative